Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Results reported for NBI-3001 in glioblastoma

Jan. 7, 2003

Phase I interim safety data reported for Reolysin in malignant glioma

Jan. 7, 2003

Azido-based photosensitizers covered by Mallinckrodt patent

Jan. 3, 2003

Potential antileukemia agents selected from series of arsonic acids

Jan. 3, 2003

Inhibition of tight junction function as a novel approach to breast cancer

Jan. 3, 2003

SuperGen submits first module of rolling NDA for Orathecin

Jan. 3, 2003

Joint development agreement signed by Beaufour Ipsen and Roche for new anticancer drugs

Jan. 3, 2003

Oxigene begins phase II trial of CA4P in thyroid cancer

Jan. 3, 2003

Discovery of Src kinase inhibitors reported by AstraZeneca

Jan. 2, 2003

New caspase activators and their use in cancer and autoimmune diseases

Jan. 2, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...